The companies are aware of the impact that disseminating their corporate social responsibility (CSR) performance has on how shareholders or investors perceive them. This work analyses if disseminating CSR results affects their economic–financial results, their scores in open‐access sustainability ranking, their brand values, and also the credit ratings that agencies S&P and Moody's confer them. For this purpose, the only 13 companies of the IT sector occupying a top 100 brand rankings position were selected. The results reveal that large companies come over as being more transparent in terms of sustainability, but this transparency is not related to their financial behaviour. Brand rankings collect socio‐economic and environmental information, but only the transparency in social and environmental aspects explains the public‐access CRS rankings. Finally, the results also show that this transparency affects credit ratings.

No abstract

Reputation is a strategic asset for firms, but has been poorly studied in the pharmaceutical industry, particularly in relation to their financial and stock-market performance. This work aimed to predict the probability of a firm being included in a pharmaceutical reputation index (Merco and PatientView), and the position it occupies, according to its economic–financial and stock-market outcomes and its geographical location. Fifty firms with excellent sales in 2019 and their rankings in 2017–2019 were employed. The methodology followed was logistic regression. Their research and development (R&D) expenditures and dividends strongly influenced them being included in both rankings. Non-Asian pharmaceutical companies were more likely to belong to the two reputation indices than Asian ones, and to occupy the best positions in the Merco ranking. Although no large differences appeared in the firms in both indices, differences were found in the position that pharmaceutical companies occupied in rankings and in the variables that contribute to them occupying these positions. Being in PatientView influenced dividends, sales, and income, while appearing in Merco showed accounting aspects like value in books and debt ratio.

On March 24, 2015, the largest air accident on the European continent of the last decade took place; the Germanwings Flight 9525 crashed. The main objective of this research is to determine the economic-financial impact of this air crash on the market stock price of the involved companies, Lufthansa airline, and its manufacturer Airbus. This study also contributes to determining whether the financial value of both companies was impacted by the media activity after the event. The primary methodology used is the event study methodology, applying both the market model and the Fama-French model. The results reveal that the impact of the Germanwings Flight 9525 on the financial value of the companies involved is different, since there is a significant effect on the financial value of Lufthansa under the market model, and this effect is immediate, but there is no significant effect on the financial value of Airbus with any of the models analyzed. In the same way, it happens when analyzing the impact of the media, since there is only a significant relationship between Lufthansa's share prices and the impact of media research with the market model. These results are important for the companies involved, and especially for their investors. It also shows that the manufacturing company is less vulnerable to the impact of the media, and it does not suffer significant losses on the stock market.